These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3163942

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
    Sun X, Zhou Z, Kang YJ.
    Cancer Res; 2001 Apr 15; 61(8):3382-7. PubMed ID: 11309296
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [A comparative study of 4'-epi-doxorubicin and doxorubicin cardiotoxicities].
    Suzuki T, Yamamoto H, Iwasaki T, Okamoto S, Iizuka T, Kanda H, Murata K.
    Gan To Kagaku Ryoho; 1984 Oct 15; 11(10):2170-6. PubMed ID: 6593004
    [Abstract] [Full Text] [Related]

  • 30. Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration.
    Gabizon A, Meshorer A, Barenholz Y.
    J Natl Cancer Inst; 1986 Aug 15; 77(2):459-69. PubMed ID: 3461207
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the effectiveness of (+/-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) and N-acetylcysteine in preventing chronic doxorubicin cardiotoxicity in beagles.
    Herman EH, Ferrans VJ, Myers CE, Van Vleet JF.
    Cancer Res; 1985 Jan 15; 45(1):276-81. PubMed ID: 3917371
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin.
    Doroshow JH, Locker GY, Myers CE.
    J Clin Invest; 1980 Jan 15; 65(1):128-35. PubMed ID: 7350193
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells.
    Kluza J, Marchetti P, Gallego MA, Lancel S, Fournier C, Loyens A, Beauvillain JC, Bailly C.
    Oncogene; 2004 Sep 16; 23(42):7018-30. PubMed ID: 15273722
    [Abstract] [Full Text] [Related]

  • 38. Activity of d,l-alpha-tocopherol (vitamin E) against cardiotoxicity induced by doxorubicin and doxorubicin with cyclophosphamide in mice.
    Bjelogrlic SK, Radic J, Jovic V, Radulovic S.
    Basic Clin Pharmacol Toxicol; 2005 Nov 16; 97(5):311-9. PubMed ID: 16236144
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.